What is Evolutionary Genomics, Inc. (FNAM)?

Evolutionary Genomics, Inc. (FNAM) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of FNAM?

The current price of FNAM is $0.00. Prices are updated in real time on Stocks360.

What is FNAM's price-to-earnings (PE) ratio?

FNAM's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is FNAM's market capitalization?

FNAM's market capitalization is $1,331.00, placing it in the small-cap tier.

Evolutionary Genomics, Inc. (FNAM)

Stock analysis · OTC · Healthcare · Biotechnology

$0.00

Market Cap

$1.33K

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

-0.12

Day Range

$0.00 – $0.45

52-wk Range

$0.00 – $0.45

Avg Volume

N/A

Volume

300.00

Evolutionary Genomics, Inc. (FNAM) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $1.33K. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 5 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-29 · $0.00 2026-10-27 · $0.00 (+0.00%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Evolutionary Genomics, Inc.

Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.00×
P/B	-0.00×
P/FCF (TTM)	-0.00×
EV / EBITDA	-3.47×
EV / Sales	0.00×
Earnings Yield	-150627.98%
Free Cash Flow Yield	-48155.52%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$3.17M
Net Income (TTM)	-$2.00M
Free Cash Flow (TTM)	-$640.95K
Net Debt	$3.17M
Working Capital	$520.67K
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Return on Equity	64.84%
Return on Invested Capital	-92.59%